BioLineRx Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $52.9M | $5.1M |
| FY2018 | — | $41.3M | $3.4M |
| FY2019 | — | $33.4M | $5.3M |
| FY2020 | — | $22.0M | $16.8M |
| FY2021 | — | $68.1M | $13.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $52.9M | $5.1M |
| FY2018 | — | $41.3M | $3.4M |
| FY2019 | — | $33.4M | $5.3M |
| FY2020 | — | $22.0M | $16.8M |
| FY2021 | — | $68.1M | $13.0M |